1. Home
  2. TKNO vs EVO Comparison

TKNO vs EVO Comparison

Compare TKNO & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Alpha Teknova Inc.

TKNO

Alpha Teknova Inc.

N/A

Current Price

$7.01

Market Cap

482.7M

Sector

Health Care

ML Signal

N/A

Logo Evotec SE

EVO

Evotec SE

N/A

Current Price

$1.56

Market Cap

568.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TKNO
EVO
Founded
1996
1993
Country
United States
Germany
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
482.7M
568.6M
IPO Year
2021
2007

Fundamental Metrics

Financial Performance
Metric
TKNO
EVO
Price
$7.01
$1.56
Analyst Decision
Strong Buy
Buy
Analyst Count
8
3
Target Price
★ $9.67
$4.23
AVG Volume (30 Days)
★ 564.9K
84.4K
Earning Date
11-04-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 43.86
N/A
EPS
N/A
★ N/A
Revenue
★ $40,520,000.00
N/A
Revenue This Year
$13.54
N/A
Revenue Next Year
$14.51
$20.47
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 7.35
N/A
52 Week Low
$1.91
$1.33
52 Week High
$9.48
$4.19

Technical Indicators

Market Signals
Indicator
TKNO
EVO
Relative Strength Index (RSI) 46.18 49.89
Support Level $6.33 $1.50
Resistance Level $7.66 $1.97
Average True Range (ATR) 0.59 0.05
MACD -0.19 0.02
Stochastic Oscillator 53.90 86.79

Price Performance

Historical Comparison
TKNO
EVO

About TKNO Alpha Teknova Inc.

Alpha Teknova Inc is a producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics. Its offer two primary product categories: Lab Essentials and Clinical Solutions. It derives key revenue from the United States. The company offers three primary product types: (i) pre-poured media plates for cell growth and cloning; (ii) liquid microbial culture media and supplements for cellular expansion; and (iii) molecular biology reagents for sample manipulation, resuspension, and purification.

About EVO Evotec SE

Evotec SE is a life science company focused on developing pharmaceutical products through standalone services, integrated R&D programs, and strategic partnerships with pharmaceutical and biotechnology companies, academic institutions, and other partners. It operates across drug discovery, preclinical development, and manufacturing, with expertise in areas including oncology, central nervous system, cardiovascular-renal, immune and inflammatory, infectious, and other diseases. The Company generates revenue through fee-for-service and FTE-based services, milestones, and royalties, and equity ownership in biotechnology and academic projects. It operates through the Shared R&D and Discovery & Preclinical Development (D&PD) segments, with the majority of revenue generated from the USA.

Share on Social Networks: